Signal detection and risk management strategies to optimise your drug safety in a post Volume 9a environment 

Date: Monday 10 - Thursday 13 December 2007

Location: NH Grande Hotel Krasnapolsky, Amsterdam, The Netherlands

WCI Consulting Limited's Chris Holmes will be speaking on Wednesday 12 December at 10:20, discussing and comparing risk minimisation strategies including current best in class practices, strategies and maturity identified across the industry and future trends.

Further confirmed Speakers include:

Nawab Qizilbash, Oxon Epidemiology
Maurits Lugard, Sidley Austin LLP
Brian Edwards, NDA Regulatory Science Limited
Dieter Konrad, Boehringer Ingelheim
Peter Nowicki, Schering AG
Kristina Starr, WHO Collaborating Centre for International Drug Monitoring
Simon Day, Roche
Martin Goldman, Forest Laboratories
John Parkinson, GRPD, MHRA
Elliot Brown, Elliot Brown Consulting
Chris Holmes, WCI Consulting Limited
Pippa Biswas, Symogen
Renald Hennig, Novartis Vaccines
Vicki R Edwards, Abbott Laboratories

For further information about the conference please visit the event website at:

http://www.informa.com/corporate/external/goto.htm?url=http://www.iir-events.com/IIR-conf/LifeSciences/Default.aspx 

For further information about WCI's involvement please contact Kate Adams at kate.adams@wcigroup.com